Dysfunctional CD8+ T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Claire Frances Friedman, Qin Zhou, Alexia Iasonos, Aliya Holland, Lizbeth Ramirez, Rachel N. Grisham, Robin Guo, Stuart M. Lichtman, Chrisann Kyi, Vicky Makker, Jennifer Jean Mueller, Roisin Eilish O'Cearbhaill, Alison M. Schram, William P. Tew, Jason A. Konner, Tiffany A. Troso-Sandoval, Andreas Georg Wibmer, Carol Aghajanian, Martee Leigh Hensley, Dmitriy Zamarin
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Stand Up To Cancer
OpenAlex ID: W4281856499